Neurofibroma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) No edit summary |
Mahshid |
||
| Line 22: | Line 22: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Revision as of 03:01, 27 November 2017
|
Neurofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neurofibroma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Neurofibroma epidemiology and demographics |
|
Risk calculators and risk factors for Neurofibroma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Neurofibroma usually affects individuals between 20 and 30 years of age.[1] Neurofibroma affects men and women equally.[1]
Epidemiology and Demographics
Age
- Neurofibroma usually affects individuals between 20 and 30 years of age.[1]
- Plexiform neurofibromas occur earlier in life and are thought to be congenital defects.[2]
Gender
- Neurofibroma affects men and women equally.[1]
References
- ↑ 1.0 1.1 1.2 1.3 Neurofibroma.Dr Bruno Di Muzio and Dr Maxime St-Amant et al. Radiopaedia.org 2015. http://radiopaedia.org/articles/neurofibroma Accessed on November 17, 2015
- ↑ "Case Based Pediatrics For Medical Students and Residents: Chapter XVIII.11. Neurofibromatosis", by Vince K. Yamashiroya, MD. August, 2002. Department of Pediatrics, University of Hawaii John A. Burns School of Medicine.